Both mental and physical health predicts one year mortality and readmissions in patients with implantable cardioverter defibrillators: findings from the national DenHeart study

Abstract

Background:

Although highly effective in preventing arrhythmic death, there is a high prevalence of anxiety, depression and reduced quality of life among patients who have received an implantable cardioverter defibrillator (ICD). Whether mortality, ICD shock and readmission are predicted by patient-reported outcomes is unknown.

Aim:

The aim of this study was to describe patient-reported outcomes among patients with ICDs compared by: ICD indication and generator type (ICD or cardiac resynchronisation therapy ICD), and to determine whether patient-reported outcomes at discharge predict mortality, ICD therapy and readmission.

Methods:

A national cross-sectional survey at hospital discharge (n=998) with register follow-up. Patient-reported outcomes included the Hospital Anxiety and Depression Scale, Short Form-12, HeartQoL, EQ-5D and Edmonton Symptom Assessment Scale. Register data: ICD therapy, readmissions and mortality within one year following discharge.

Results:

Patients with primary prevention ICDs had significantly worse patient-reported outcomes at discharge than patients with secondary prevention ICDs. Likewise, patients with cardiac resynchronisation therapy ICDs had significantly worse patient-reported outcomes at discharge than patients without cardiac resynchronisation therapy. One-year mortality was predicted by patient-reported outcomes, with the highest hazard ratio (HR) being anxiety (HR 2.02; 1.06–3.86), but was not predicted by indication or cardiac resynchronisation therapy. ICD therapy and ventricular tachycardia/ventricular fibrillation were not predicted by patient-reported outcomes, indication or cardiac resynchronisation therapy. Overall, patient-reported outcomes predicted readmissions, e.g. symptoms of anxiety and depression predicted all readmissions within 3 months (HR 1.50; 1.13–1.98) and 1.47 (1.07–2.03), respectively).

Conclusion:

Patients with primary indication ICDs and cardiac resynchronisation therapy ICDs report worse patient-reported outcomes than patients with secondary indication and no cardiac resynchronisation therapy. Patient-reported outcomes such as mental health, quality of life and symptom burden predict one-year mortality and acute and planned hospital readmissions.

Keywords

Implantable defibrillators mortality patient readmission patient reported outcome measures

Get full access to this article

View all access options for this article.

References

Al-Khatib

Sanders

Carlson

et al . Preventing tomorrow’s sudden cardiac death today: dissemination of effective therapies for sudden cardiac death prevention. Am Heart J. 2008; 156: 613–622.

Dunbar

Dougherty

Sears

et al . Educational and psychological interventions to improve outcomes for recipients of implantable cardioverter defibrillators and their families: a scientific statement from the American Heart Association. Circulation 2012; 126: 2146–2172.

Pedersen

Hoogwegt

Jordaens

et al . Pre implantation psychological functioning preserved in majority of implantable cardioverter defibrillator patients 12 months post implantation. Int J Cardiol 2013; 166: 215–220.

Carroll

Arthur

HM.

A comparative study of uncertainty, optimism and anxiety in patients receiving their first implantable defibrillator for primary or secondary prevention of sudden cardiac death. Int J Nurs Stud 2010; 47: 836–845.

Theuns

Schaer

Soliman

et al . The prognosis of implantable defibrillator patients treated with cardiac resynchronization therapy: comorbidity burden as predictor of mortality. Europace 2011; 13: 62–69.

Bhavnani

Coleman

Guertin

et al . Evaluation of the Charlson comorbidity index to predict early mortality in implantable cardioverter defibrillator patients. Ann Noninvasive Electrocardiol 2013; 18: 379–388.

Pedersen

Sears

Burg

et al . Does ICD indication affect quality of life and levels of distress? Pacing Clin Electrophysiol 2009; 32: 153–156.

Magyar-Russell

Thombs

Cai

et al . The prevalence of anxiety and depression in adults with implantable cardioverter defibrillators: a systematic review. J Psychosom Res 2011; 71: 223–231.

Gostoli

Bonomo

Roncuzzi

et al . Psychological correlates, allostatic overload and clinical course in patients with implantable cardioverter defibrillator (ICD). Int J Cardiol 2016; 220: 360–364.

10.

Pedersen

Brouwers

Versteeg

Psychological vulnerability, ventricular tachyarrhythmias and mortality in implantable cardioverter defibrillator patients: is there a link?

Expert Rev Med Devices 2012; 9: 377–388.

11.

Lang

Becker

Wilke

et al . Anxiety disorders in patients with implantable cardioverter defibrillators: frequency, course, predictors, and patients’ requests for treatment. Pacing Clin Electrophysiol 2014; 37: 35–47.

12.

Rumsfeld

Alexander

Goff

Jr et al . Cardiovascular health: the importance of measuring patient-reported health status: a scientific statement from the American Heart Association. Circulation 2013; 12): 2233–2249.

13.

Berg

Svanholm

Lauberg

et al . Patient-reported outcomes at hospital discharge from heart centres, a national cross-sectional survey with a register-based follow-up: the DenHeart study protocol. BMJ Open 2014; 4: e004709.

14.

Ware

Jr Kosinski

Keller

SD.

A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34: 220–233.

15.

De Smedt

Clays

Doyle

et al . Validity and reliability of three commonly used quality of life measures in a large European population of coronary heart disease patients. Int J Cardiol 2013; 167: 2294–2299.

16.

Zigmond

Snaith

RP.

The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361–370.

17.

Bjelland

Dahl

Haug

et al . The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002; 52: 69–77.

18.

Rabin

de Charro

EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001; 33: 337–343.

19.

Oldridge

Hofer

McGee

et al . The HeartQoL: Part I. Development of a new core health-related quality of life questionnaire for patients with ischemic heart disease. Eur J Prev Cardiol 2014; 21: 90–97.

20.

Oldridge

Hofer

McGee

et al . The HeartQoL: Part II. Validation of a new core health-related quality of life questionnaire for patients with ischemic heart disease. Eur J Prev Cardiol 2014; 21: 98–106.

21.

Oldridge

Saner

McGee

; HeartQoL Study Investigators. The Euro Cardio-QoL Project. An international study to develop a core heart disease health-related quality of life questionnaire, the HeartQoL. Eur J Cardiovasc Prev Rehabil 2005; 12: 87–94.

22.

Zangger

Zwisler

Kikkenborg Berg

et al . Psychometric properties of HeartQoL, a core heart disease-specific health-related quality of life questionnaire, in Danish implantable cardioverter defibrillator recipients. Eur J Prev Cardiol 2018; 25: 142–149.

23.

Kristensen

Zwisler

Berg

et al . Validating the HeartQoL questionnaire in patients with atrial fibrillation. Eur J Prev Cardiol 2016; 23: 1496–1503.

24.

Chang

Hwang

Feuerman

Validation of the Edmonton Symptom Assessment Scale. Cancer 2000; 88: 2164–2171.

25.

Ekholm

Hesse

Davidsen

et al . The study design and characteristics of the Danish national health interview surveys. Scand J Public Health 2009; 37: 758–765.

26.

Christensen

Ekholm

Glumer

et al . The Danish National Health Survey 2010. Study design and respondent characteristics. Scand J Public Health 2012; 40: 391–397.

27.

Pedersen

CB.

The Danish Civil Registration System. Scand J Public Health 2011; 39 (7 Suppl.): 22–25.

28.

Lynge

Sandegaard

Rebolj

The Danish National Patient Register. Scand J Public Health 2011; 39 (7 Suppl.): 30–33.

29.

Austin

Walld

et al . Development and validation of the Ontario acute myocardial infarction mortality prediction rules. J Am Coll Cardiol 2001; 37: 992–997.

30.

Berg

Thorup

Borregaard

et al . Patient-reported outcomes are independent predictors of one-year mortality and cardiac events across cardiac diagnoses: findings from the national DenHeart survey. Eur J Prev Cardiol 2018; 112: 66–72.

31.

Rothman

Greenland

Lash

TL.

Modern Epidemiology, 3rd edn. Philadelphia: Lippincott Williams & Wilkins, 2008.

32.

Anker

Agewall

Borggrefe

et al . The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trials. Eur Heart J 2014; 35: 2001–2009.

33.

Versteeg

Timmermans

Meine

et al . Prevalence and risk markers of early psychological distress after ICD implantation in the European REMOTE-CIED study cohort. Int J Cardiol 2017; 240: 208–213.

34.

Berg

Thygesen

Svendsen

et al . Anxiety predicts mortality in ICD patients: results from the Cross-Sectional National Copenheart Survey with Register Follow-Up. Pacing Clin Electrophysiol 2014; 37: 1641–1650.

35.

Thylen

Dekker

Jaarsma

et al . Characteristics associated with anxiety, depressive symptoms, and quality-of-life in a large cohort of implantable cardioverter defibrillator recipients. J Psychosom Res 2014; 77: 122–127.

36.

Whang

Albert

Sears

Jr et al . Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators: results from the Triggers of Ventricular Arrhythmias (TOVA) study. J Am Coll Cardiol 2005; 45: 1090–1095.

37.

Magnusson

Morner

Gadler

et al . Health-related quality of life in hypertrophic cardiomyopathy patients with implantable defibrillators. Health Qual Life Outcomes 2016; 14: 62–016–0467-x.

38.

Berg

Rasmussen

Thrysoee

et al . DenHeart: differences in physical and mental health across cardiac diagnoses at hospital discharge. J Psychosom Res 2017; 94: 1–9.

39.

Pedersen

van den Broek

Erdman

et al . Pre-implantation implantable cardioverter defibrillator concerns and type D personality increase the risk of mortality in patients with an implantable cardioverter defibrillator. Europace 2010; 12: 1446–1452.

40.

Versteeg

van ’t Sant

Cramer

et al . Discrepancy between echocardiographic and patient-reported health status response to cardiac resynchronization therapy: results of the PSYHEART-CRT study. Eur J Heart Fail 2014; 16: 227–234.

41.

Bergau

Tichelbacker

Kessel

et al . Predictors of mortality and ICD shock therapy in primary prophylactic ICD patients – a systematic review and meta-analysis. PLoS One 2017; 12: e0186387.

42.

Berg

Pedersen

Zwisler

et al . Comprehensive cardiac rehabilitation improves outcome for patients with implantable cardioverter defibrillator. Findings from the COPE-ICD randomized clinical trial. Eur J Cardiovasc Nurs 2015; 14: 34–44.

43.

Berg

Herning

Svendsen

et al . The Screen-ICD trial. Screening for anxiety and cognitive therapy intervention for patients with implanted cardioverter defibrillator (ICD): a randomised controlled trial protocol. BMJ Open 2016; 6: e013186.

44.

Maia

Braga

Soares-Filho

et al . Efficacy of cognitive behavioral therapy in reducing psychiatric symptoms in patients with implantable cardioverter defibrillator: an integrative review. Braz J Med Biol Res 2014; 47: 265–272.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.01 MB